ReP USP - Resultado da busca

Artigo de periodico
Immunoconjugates for cancer targeting: a review of antibody-drug conjugates and antibody-functionalized nanoparticles (2021)
Petrilli, Raquel; Pinheiro, Daniel Pascoalino; Oliveira, Fátima de Cássia Evangelista de; Galvão, Gabriela Fávero; Marques, Lana Grasiela Alves; Lopez, Renata Fonseca Vianna ; Pessoa, Claudia; Eloy, Josimar O.
Fonte: Current Medicinal Chemistry. Unidade: FCFRP
Assuntos: ANTICORPOS MONOCLONAIS, ANTINEOPLÁSICOS, NANOPARTÍCULAS, NEOPLASIAS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRILLI, Raquel et al. Immunoconjugates for cancer targeting: a review of antibody-drug conjugates and antibody-functionalized nanoparticles. Current Medicinal Chemistry, v. 28, n. 13, p. 2485-2520, 2021Tradução . . Disponível em: https://doi.org/10.2174/0929867327666200525161359. Acesso em: 23 out. 2025.
APA
Petrilli, R., Pinheiro, D. P., Oliveira, F. de C. E. de, Galvão, G. F., Marques, L. G. A., Lopez, R. F. V., et al. (2021). Immunoconjugates for cancer targeting: a review of antibody-drug conjugates and antibody-functionalized nanoparticles. Current Medicinal Chemistry, 28( 13), 2485-2520. doi:10.2174/0929867327666200525161359
NLM
Petrilli R, Pinheiro DP, Oliveira F de CE de, Galvão GF, Marques LGA, Lopez RFV, Pessoa C, Eloy JO. Immunoconjugates for cancer targeting: a review of antibody-drug conjugates and antibody-functionalized nanoparticles [Internet]. Current Medicinal Chemistry. 2021 ; 28( 13): 2485-2520.[citado 2025 out. 23 ] Available from: https://doi.org/10.2174/0929867327666200525161359
Vancouver
Petrilli R, Pinheiro DP, Oliveira F de CE de, Galvão GF, Marques LGA, Lopez RFV, Pessoa C, Eloy JO. Immunoconjugates for cancer targeting: a review of antibody-drug conjugates and antibody-functionalized nanoparticles [Internet]. Current Medicinal Chemistry. 2021 ; 28( 13): 2485-2520.[citado 2025 out. 23 ] Available from: https://doi.org/10.2174/0929867327666200525161359
Artigo de periodico
A critical review of properties and analytical/bioanalytical methods for characterization of cetuximab (2020)
Hanck-Silva, Gilmar; Trevizan, Lucas Noboru Fatori; Petrilli, Raquel ; Lima, Felipe Tita de; Eloy, Josimar O.; Chorilli, Marlus
Fonte: Critical Reviews in Analytical Chemistry. Unidade: FCFRP
Assuntos: RECEPTORES, ESPECTROFOTOMETRIA, ANIMAIS, ENSAIO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HANCK-SILVA, Gilmar et al. A critical review of properties and analytical/bioanalytical methods for characterization of cetuximab. Critical Reviews in Analytical Chemistry, v. 50, n. 2, p. 125-135, 2020Tradução . . Disponível em: https://doi.org/10.1080/10408347.2019.1581984. Acesso em: 23 out. 2025.
APA
Hanck-Silva, G., Trevizan, L. N. F., Petrilli, R., Lima, F. T. de, Eloy, J. O., & Chorilli, M. (2020). A critical review of properties and analytical/bioanalytical methods for characterization of cetuximab. Critical Reviews in Analytical Chemistry, 50( 2), 125-135. doi:10.1080/10408347.2019.1581984
NLM
Hanck-Silva G, Trevizan LNF, Petrilli R, Lima FT de, Eloy JO, Chorilli M. A critical review of properties and analytical/bioanalytical methods for characterization of cetuximab [Internet]. Critical Reviews in Analytical Chemistry. 2020 ; 50( 2): 125-135.[citado 2025 out. 23 ] Available from: https://doi.org/10.1080/10408347.2019.1581984
Vancouver
Hanck-Silva G, Trevizan LNF, Petrilli R, Lima FT de, Eloy JO, Chorilli M. A critical review of properties and analytical/bioanalytical methods for characterization of cetuximab [Internet]. Critical Reviews in Analytical Chemistry. 2020 ; 50( 2): 125-135.[citado 2025 out. 23 ] Available from: https://doi.org/10.1080/10408347.2019.1581984
Artigo de periodico
Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models (2018)
Praça, Fabíola Silva Garcia; Medina, Wanessa Silva Garcia; Eloy, Josimar O.; Petrilli, Raquel; Campos, Patrícia Mazureki; Ascenso, Andreia; Bentley, Maria Vitória Lopes Badra
Fonte: European Journal of Pharmaceutical Sciences. Unidade: FCFRP
Assuntos: CIÊNCIAS DA SAÚDE, PELES, CONGELAMENTO, CRIOPRESERVAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRAÇA, Fabíola Silva Garcia et al. Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models. European Journal of Pharmaceutical Sciences, v. 111, p. 121-132, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2017.09.034. Acesso em: 23 out. 2025.
APA
Praça, F. S. G., Medina, W. S. G., Eloy, J. O., Petrilli, R., Campos, P. M., Ascenso, A., & Bentley, M. V. L. B. (2018). Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models. European Journal of Pharmaceutical Sciences, 111, 121-132. doi:10.1016/j.ejps.2017.09.034
NLM
Praça FSG, Medina WSG, Eloy JO, Petrilli R, Campos PM, Ascenso A, Bentley MVLB. Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models [Internet]. European Journal of Pharmaceutical Sciences. 2018 ; 111 121-132.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.ejps.2017.09.034
Vancouver
Praça FSG, Medina WSG, Eloy JO, Petrilli R, Campos PM, Ascenso A, Bentley MVLB. Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models [Internet]. European Journal of Pharmaceutical Sciences. 2018 ; 111 121-132.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.ejps.2017.09.034
Artigo de periodico
Ketoprofen microemulsion for improved skin delivery and in vivo anti-inflammatory effect (2017)
Aliberti, Ana Luisa Murbach; Queiroz, Alemer Cortat de; Praça, Fabíola Silva Garcia; Eloy, Josimar O.; Bentley, Maria Vitória Lopes Badra; Medina, Wanessa Silva Garcia
Fonte: AAPS PharmSciTech. Unidade: FCFRP
Assuntos: EMULSÕES (FORMAS FARMACÊUTICAS), ANTI-INFLAMATÓRIOS, PELE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALIBERTI, Ana Luisa Murbach et al. Ketoprofen microemulsion for improved skin delivery and in vivo anti-inflammatory effect. AAPS PharmSciTech, v. 18, n. 7, p. 2783-2791, 2017Tradução . . Disponível em: https://doi.org/10.1208/s12249-017-0749-6. Acesso em: 23 out. 2025.
APA
Aliberti, A. L. M., Queiroz, A. C. de, Praça, F. S. G., Eloy, J. O., Bentley, M. V. L. B., & Medina, W. S. G. (2017). Ketoprofen microemulsion for improved skin delivery and in vivo anti-inflammatory effect. AAPS PharmSciTech, 18( 7), 2783-2791. doi:10.1208/s12249-017-0749-6
NLM
Aliberti ALM, Queiroz AC de, Praça FSG, Eloy JO, Bentley MVLB, Medina WSG. Ketoprofen microemulsion for improved skin delivery and in vivo anti-inflammatory effect [Internet]. AAPS PharmSciTech. 2017 ; 18( 7): 2783-2791.[citado 2025 out. 23 ] Available from: https://doi.org/10.1208/s12249-017-0749-6
Vancouver
Aliberti ALM, Queiroz AC de, Praça FSG, Eloy JO, Bentley MVLB, Medina WSG. Ketoprofen microemulsion for improved skin delivery and in vivo anti-inflammatory effect [Internet]. AAPS PharmSciTech. 2017 ; 18( 7): 2783-2791.[citado 2025 out. 23 ] Available from: https://doi.org/10.1208/s12249-017-0749-6
Artigo de periodico
Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection (2017)
Abriata, Juliana Palma; Eloy, Josimar O.; Riul, Thalita Bachelli; Campos, Patricia Mazureki; Baruffi, Marcelo Dias; Marchetti, Juliana Maldonado
Fonte: Materials Science and Engineering: C. Unidade: FCFRP
Assuntos: NANOPARTÍCULAS, TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS, BIODISPONIBILIDADE, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABRIATA, Juliana Palma et al. Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection. Materials Science and Engineering: C, v. 77, p. 1196-1203, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2017.03.266. Acesso em: 23 out. 2025.
APA
Abriata, J. P., Eloy, J. O., Riul, T. B., Campos, P. M., Baruffi, M. D., & Marchetti, J. M. (2017). Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection. Materials Science and Engineering: C, 77, 1196-1203. doi:10.1016/j.msec.2017.03.266
NLM
Abriata JP, Eloy JO, Riul TB, Campos PM, Baruffi MD, Marchetti JM. Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection [Internet]. Materials Science and Engineering: C. 2017 ; 77 1196-1203.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.msec.2017.03.266
Vancouver
Abriata JP, Eloy JO, Riul TB, Campos PM, Baruffi MD, Marchetti JM. Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection [Internet]. Materials Science and Engineering: C. 2017 ; 77 1196-1203.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.msec.2017.03.266
Artigo de periodico
Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy (2017)
Eloy, Josimar O.; Petrilli, Raquel; Chesca, Deise Lúcia; Saggioro, Fabiano Pinto; Lee, Robert J.; Marchetti, Juliana Maldonado
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FMRP, SVOI, FCFRP
Assuntos: ANTICORPOS MONOCLONAIS, NEOPLASIAS MAMÁRIAS, LIPOSSOMOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, v. 115, p. 159-167, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2017.02.020. Acesso em: 23 out. 2025.
APA
Eloy, J. O., Petrilli, R., Chesca, D. L., Saggioro, F. P., Lee, R. J., & Marchetti, J. M. (2017). Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, 115, 159-167. doi:10.1016/j.ejpb.2017.02.020
NLM
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Vancouver
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Artigo de periodico
Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells (2017)
Eloy, Josimar O.; Petrilli, Raquel; Brueggemeier, Robert W.; Marchetti, Juliana Maldonado; Lee, Robert J.
Fonte: Anti-Cancer Agents in Medicinal Chemistry. Unidade: FCFRP
Assuntos: ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells. Anti-Cancer Agents in Medicinal Chemistry, v. 17, n. 1, p. 48-56, 2017Tradução . . Disponível em: https://doi.org/10.2174/1871520616666160526103432. Acesso em: 23 out. 2025.
APA
Eloy, J. O., Petrilli, R., Brueggemeier, R. W., Marchetti, J. M., & Lee, R. J. (2017). Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells. Anti-Cancer Agents in Medicinal Chemistry, 17( 1), 48-56. doi:10.2174/1871520616666160526103432
NLM
Eloy JO, Petrilli R, Brueggemeier RW, Marchetti JM, Lee RJ. Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2017 ; 17( 1): 48-56.[citado 2025 out. 23 ] Available from: https://doi.org/10.2174/1871520616666160526103432
Vancouver
Eloy JO, Petrilli R, Brueggemeier RW, Marchetti JM, Lee RJ. Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2017 ; 17( 1): 48-56.[citado 2025 out. 23 ] Available from: https://doi.org/10.2174/1871520616666160526103432
Artigo de periodico
Cetuximab immunoliposomes enhance delivery of 5-FU to skin squamous carcinoma cells (2017)
Petrilli, Raquel; Eloy, Josimar O.; Lopez, Renata Fonseca Vianna; Lee, Robert J.
Fonte: Anti-Cancer Agents in Medicinal Chemistry. Unidade: FCFRP
Assuntos: ANTINEOPLÁSICOS, NEOPLASIAS CUTÂNEAS, CARCINOMA DE CÉLULAS ESCAMOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRILLI, Raquel et al. Cetuximab immunoliposomes enhance delivery of 5-FU to skin squamous carcinoma cells. Anti-Cancer Agents in Medicinal Chemistry, v. 17, n. 2, p. 301-308, 2017Tradução . . Disponível em: https://doi.org/10.2174/1871520616666160526110913. Acesso em: 23 out. 2025.
APA
Petrilli, R., Eloy, J. O., Lopez, R. F. V., & Lee, R. J. (2017). Cetuximab immunoliposomes enhance delivery of 5-FU to skin squamous carcinoma cells. Anti-Cancer Agents in Medicinal Chemistry, 17( 2), 301-308. doi:10.2174/1871520616666160526110913
NLM
Petrilli R, Eloy JO, Lopez RFV, Lee RJ. Cetuximab immunoliposomes enhance delivery of 5-FU to skin squamous carcinoma cells [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2017 ; 17( 2): 301-308.[citado 2025 out. 23 ] Available from: https://doi.org/10.2174/1871520616666160526110913
Vancouver
Petrilli R, Eloy JO, Lopez RFV, Lee RJ. Cetuximab immunoliposomes enhance delivery of 5-FU to skin squamous carcinoma cells [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2017 ; 17( 2): 301-308.[citado 2025 out. 23 ] Available from: https://doi.org/10.2174/1871520616666160526110913
Artigo de periodico
Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy (2016)
Eloy, Josimar O.; Petrilli, Raquel; Topan, José Fernando; Antonio, Heriton Marcelo Ribeiro; Barcellos, Juliana Palma Abriata; Chesca, Deise Lúcia; Serafini, Luciano Neder; Tiezzi, Daniel Guimarães; Lee, Robert J.; Marchetti, Juliana Maldonado
Fonte: Colloids and Surfaces B: Biointerfaces. Unidades: FMRP, FCFRP
Assuntos: NEOPLASIAS MAMÁRIAS, LIPOSSOMOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Colloids and Surfaces B: Biointerfaces, v. 141, p. 74-82, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2016.01.032. Acesso em: 23 out. 2025.
APA
Eloy, J. O., Petrilli, R., Topan, J. F., Antonio, H. M. R., Barcellos, J. P. A., Chesca, D. L., et al. (2016). Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Colloids and Surfaces B: Biointerfaces, 141, 74-82. doi:10.1016/j.colsurfb.2016.01.032
NLM
Eloy JO, Petrilli R, Topan JF, Antonio HMR, Barcellos JPA, Chesca DL, Serafini LN, Tiezzi DG, Lee RJ, Marchetti JM. Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy [Internet]. Colloids and Surfaces B: Biointerfaces. 2016 ; 141 74-82.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.colsurfb.2016.01.032
Vancouver
Eloy JO, Petrilli R, Topan JF, Antonio HMR, Barcellos JPA, Chesca DL, Serafini LN, Tiezzi DG, Lee RJ, Marchetti JM. Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy [Internet]. Colloids and Surfaces B: Biointerfaces. 2016 ; 141 74-82.[citado 2025 out. 23 ] Available from: https://doi.org/10.1016/j.colsurfb.2016.01.032
Artigo de periodico
Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles (2015)
Souza, Marina Claro de; Marotta-Oliveira, Samantha Sant'Anna; Rocha, Nathália Helena Souza; Eloy, Josimar O.; Marchetti, Juliana Maldonado
Fonte: Journal of Liquid Chromatography and Related Technologies. Unidade: FCFRP
Assuntos: NEOPLASIAS MAMÁRIAS, ESTRÓGENOS, CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Marina Claro de et al. Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles. Journal of Liquid Chromatography and Related Technologies, v. 38, n. 12, p. 1223-1229, 2015Tradução . . Disponível em: https://doi.org/10.1080/10826076.2015.1032418. Acesso em: 23 out. 2025.
APA
Souza, M. C. de, Marotta-Oliveira, S. S. 'A., Rocha, N. H. S., Eloy, J. O., & Marchetti, J. M. (2015). Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles. Journal of Liquid Chromatography and Related Technologies, 38( 12), 1223-1229. doi:10.1080/10826076.2015.1032418
NLM
Souza MC de, Marotta-Oliveira SS'A, Rocha NHS, Eloy JO, Marchetti JM. Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles [Internet]. Journal of Liquid Chromatography and Related Technologies. 2015 ; 38( 12): 1223-1229.[citado 2025 out. 23 ] Available from: https://doi.org/10.1080/10826076.2015.1032418
Vancouver
Souza MC de, Marotta-Oliveira SS'A, Rocha NHS, Eloy JO, Marchetti JM. Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles [Internet]. Journal of Liquid Chromatography and Related Technologies. 2015 ; 38( 12): 1223-1229.[citado 2025 out. 23 ] Available from: https://doi.org/10.1080/10826076.2015.1032418

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada